A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab
Colorectal cancer: Potential treatment for drug-resistant cases A recently identified small molecule shows promise for tackling resistance to a leading colorectal cancer drug. Three proteins that are over-expressed in colorectal cancer are epidermal growth factor receptor (EGFR), RAS and β-catenin....
Sparad:
| Huvudupphov: | , , , , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Nature Publishing Group
2018-11-01
|
| Serie: | Experimental and Molecular Medicine |
| Länkar: | https://doi.org/10.1038/s12276-018-0182-2 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|